Resultados de la búsqueda - Portal de Modelos de Datos Médicos (MDM-Portal)

Filtrar resultados de búsqueda
Seleccionar modelos de datos

Modelos de datos seleccionados

Debe iniciar sesión para seleccionar modelos de datos para descargar o realizar un análisis.

4 Resultados de la búsqueda.

Eligibility Eversion in Dermatologic Surgery NCT01770002

- 22/9/18 - 1 formulario, 2 itemgroups, 10 items, 1 idioma

Itemgroups: Inclusion Criteria, Exclusion Criteria

Eversion in Dermatologic Surgery: Is Cosmetic Appearance Improved?; ODM derived from: https://clinicaltrials.gov/show/NCT01770002 Sponsor: University of California, Davis Information provided by (Responsible Party): University of California, Davis Principal Investigator: Daniel Eisen, M.D. University of California, Davis

Clinical activity of recMAGE-A3 + AS15 in patients with metastatic cutaneous melanoma NCT00942162 - Radiotherapy; Local Surgery (Report Final and Annex Report 2 Final)

- 30/10/20 - 1 formulario, 5 itemgroups, 17 items, 1 idioma

Itemgroups: Administrative, Radiotherapy, Radiotherapy , Local Surgery, Local Surgery

Study ID: 111476 Clinical Study ID: 111476 Study Title: An open, single-arm trial to assess the clinical activity of recMAGE-A3 + AS15 in patients with unresectable MAGE-A3-positive metastatic cutaneous melanoma Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00942162 Sponsor: GlaxoSmithKline Phase: Phase 2 Study Recruitment Status: Completed Generic Name: Antigen-Specific Cancer Immunotherapeutic Study Indication: Melanoma

Eligibility Psoriatic Arthritis NCT02349295

- 24/6/19 - 1 formulario, 2 itemgroups, 14 items, 1 idioma

Itemgroups: Inclusion Criteria, Exclusion Criteria

A Study of Ixekizumab (LY2439821) in Participants With Active Psoriatic Arthritis; ODM derived from: https://clinicaltrials.gov/show/NCT02349295

Eligibility Psoriatic Arthritis NCT01989468

- 24/6/19 - 1 formulario, 2 itemgroups, 10 items, 1 idioma

Itemgroups: Inclusion Criteria, Exclusion Criteria

24 Week Efficacy and 3-year Safety and Efficacy of Secukinumab in Active Psoriatic Arthritis; ODM derived from: https://clinicaltrials.gov/show/NCT01989468

Utilice este formulario para comentarios, preguntas y sugerencias.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.